Women whose pregnancies are complicated by hyperemesis gravidarum in the second trimester are at a much higher risk of placental dysfunction disorders such as placental abruption and small-for-gestational age (SGA) babies, according to a study appearing in the January 30, 2013, issue of BJOG: An International Journal of Obstetrics and Gynaecology.
Women whose pregnancies are complicated by hyperemesis gravidarum in the second trimester are at a much higher risk of placental dysfunction disorders such as placental abruption and small-for-gestational age (SGA) babies, according to a study appearing in the January 30, 2013, issue of BJOG: An International Journal of Obstetrics and Gynaecology.
The population-based cohort study-which evaluated 1,156,050 pregnancies in the Swedish Medical Birth Register between 1997 and 2009-found that women with hyperemesis gravidarum in the first trimester had only a slightly increased risk of preeclampsia.
Women with hyperemesis gravidarum with first admission to a hospital in the second trimester had a more than doubled risk of preterm (<37 weeks) preeclampsia, a threefold increased risk of placental abruption, and a 39% increased risk of a SGA newborn. Adjusted odds ratios [95% confidence intervals] were: 2.09 [1.38–3.16], 3.07 [1.88–5.00] and 1.39 [1.06–1.83], respectively.
The researchers note that their findings suggest that hyperemesis gravidarum could be associated with abnormal placentation. “As hCG levels may be both a cause and an effect of placentation, the time of onset of hyperemesis gravidarum may influence the risks of abnormal placentation disorders,” they write. “In very early pregnancy, high hCG levels may favour normal pregnancy development, whereas, later in pregnancy, abnormal placentation may cause high hCG levels.”
To the researchers’ knowledge, no previous study has investigated hyperemesis gravidarum occurring in the first and second trimesters separately when studying associations with adverse pregnancy outcomes.
Bolin M, Åkerud H, Cnattingius S, Stephansson O, Wikström A. Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study. BJOG. 2013. Epub ahead of print.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
Read More
Echogenic Mass identified as key predictor for retained products of conception
May 13th 2024Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.
Read More